Literature DB >> 8131871

Oncogenic osteomalacia induced by schwannoma in a patient with neurofibromatosis.

D Ben-Baruch1, Y Ziv, J Sandbank, Y Wolloch.   

Abstract

A 62-year-old woman known to be suffering from Von Recklinghausen disease and osteomalacia was operated on for a pelvic mass. Pathological examination of the excised tumor showed it to be a schwannoma and this tumor was considered to be responsible for the osteomalacia. The return of previously abnormal laboratory data to normal values and the impressive clinical and subjective improvement further support the assumption that the excised schwannoma was responsible for the pathology observed in this patient.

Entities:  

Mesh:

Year:  1994        PMID: 8131871

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  5 in total

1.  Tumor-Induced Osteomalacia.

Authors:  Rajiv Kumar; Andrew L Folpe; Brian P Mullan
Journal:  Transl Endocrinol Metab       Date:  2015

2.  Striking pathology gold: a singular experience with daily reverberations: sinonasal hemangiopericytoma (glomangiopericytoma) and oncogenic osteomalacia.

Authors:  Margaret Brandwein-Gensler; Gene P Siegal
Journal:  Head Neck Pathol       Date:  2012-03-20

3.  Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin.

Authors:  Mateusz Kolanczyk; Jirko Kühnisch; Nadine Kossler; Monika Osswald; Sabine Stumpp; Boris Thurisch; Uwe Kornak; Stefan Mundlos
Journal:  BMC Med       Date:  2008-07-31       Impact factor: 8.775

4.  Tumor-induced Osteomalacia: A Sherlock Holmes Approach to Diagnosis and Management.

Authors:  G V Chanukya; Manoj Mengade; Jagadishwar Goud; I Satish Rao; Anuj Jain
Journal:  Ann Maxillofac Surg       Date:  2017 Jan-Jun

5.  Neurofibromatosis type 1 associated with hypophosphatemic osteomalacia due to hypersecretion of fibroblast growth factor 23: a case report.

Authors:  Takahiko Obo; Nobuyuki Koriyama; Akinori Tokito; Kazuma Ogiso; Yoshihiko Nishio
Journal:  J Med Case Rep       Date:  2020-05-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.